GB0818071D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0818071D0
GB0818071D0 GBGB0818071.3A GB0818071A GB0818071D0 GB 0818071 D0 GB0818071 D0 GB 0818071D0 GB 0818071 A GB0818071 A GB 0818071A GB 0818071 D0 GB0818071 D0 GB 0818071D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0818071.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0818071.3A priority Critical patent/GB0818071D0/en
Publication of GB0818071D0 publication Critical patent/GB0818071D0/en
Priority to PCT/EP2009/062652 priority patent/WO2010037760A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0818071.3A 2008-10-02 2008-10-02 Compounds Ceased GB0818071D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0818071.3A GB0818071D0 (en) 2008-10-02 2008-10-02 Compounds
PCT/EP2009/062652 WO2010037760A1 (en) 2008-10-02 2009-09-30 Compounds which potentiate ampa receptor and uses thereof in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0818071.3A GB0818071D0 (en) 2008-10-02 2008-10-02 Compounds

Publications (1)

Publication Number Publication Date
GB0818071D0 true GB0818071D0 (en) 2008-11-05

Family

ID=40019961

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0818071.3A Ceased GB0818071D0 (en) 2008-10-02 2008-10-02 Compounds

Country Status (2)

Country Link
GB (1) GB0818071D0 (en)
WO (1) WO2010037760A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338745A1 (en) * 1998-07-31 2000-02-10 Hamideh Zarrinmayeh Heterocyclyl sulphonamide derivatives
NZ552979A (en) * 2004-08-09 2010-02-26 Glaxo Group Ltd Indane and tetralin derivatives which potentiate glutamate receptor and uses thereof in medicine

Also Published As

Publication number Publication date
WO2010037760A1 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
GB0807862D0 (en) Compounds
GB0800035D0 (en) Compounds
GB0809776D0 (en) Compounds
GB0807103D0 (en) Compounds
GB0800367D0 (en) Compounds
GB0807910D0 (en) Compounds
GB0801220D0 (en) Compounds
GB0801265D0 (en) Compounds
GB0805498D0 (en) Compounds
GB0806448D0 (en) Compounds
GB0800961D0 (en) Compounds
GB0801219D0 (en) Compounds
GB0801596D0 (en) Compounds
GB0802191D0 (en) Compounds
GB0802192D0 (en) Compounds
GB0802231D0 (en) Compounds
GB0802586D0 (en) Compounds
GB0802587D0 (en) Compounds
GB0803493D0 (en) Compounds
GB0803495D0 (en) Compounds
GB0803496D0 (en) Compounds
GB0804064D0 (en) Compounds
GB0805048D0 (en) Niovel compounds
GB0805311D0 (en) Compounds
GB0800455D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)